Adalimumab treatment for chronic recurrent Vogt-Koyanagi-Harada disease with sunset glow fundus: A multicenter study

PURPOSE: We investigated the efficacy and safety of adalimumab (ADA) treatment for chronic recurrent Vogt-Koyanagi-Harada (VKH) patients with sunset glow fundus (SGF). METHODS: Medical records of 50 chronic recurrent VKH patients with SGF who received ADA treatment for more than 6 months were retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Masaru, Nakai, Shunsaku, Usui, Yoshihiko, Namba, Kenichi, Suzuki, Kayo, Harada, Yosuke, Kusuhara, Sentaro, Kaburaki, Toshikatsu, Tanaka, Rie, Takeuchi, Masaki, Mizuki, Nobuhisa, Nakai, Kei, Goto, Hiroshi, Herbort, Carl P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811924/
https://www.ncbi.nlm.nih.gov/pubmed/36618573
http://dx.doi.org/10.4103/sjopt.sjopt_204_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811924/
https://www.ncbi.nlm.nih.gov/pubmed/36618573
http://dx.doi.org/10.4103/sjopt.sjopt_204_22

Ejemplares similares